DK Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,204	1,959	2,403	3,424	1,381	6,553
Short-Term Investments	500	700	2,150	450	3,150	1,670
Trading Asset Securities	2,619	4,594	-	-	-	-
Cash & Short-Term Investments	8,323	7,254	4,553	3,874	4,531	8,223
Cash Growth	-26.44%	59.31%	17.54%	-14.50%	-44.90%	-61.82%
Accounts Receivable	95,413	90,658	63,908	57,057	47,299	45,889
Other Receivables	1,768	1,596	1,414	1,163	1,122	2,101
Receivables	97,193	92,270	65,416	58,354	48,588	48,214
Inventory	27,988	35,230	42,258	39,647	29,346	19,980
Prepaid Expenses	23.45	88.85	234.55	55.05	59.63	45.75
Other Current Assets	3,776	3,719	3,196	990.08	1,330	2,941
Total Current Assets	137,304	138,560	115,658	102,920	83,854	79,403
Property, Plant & Equipment	71,197	68,254	64,700	64,749	65,106	54,218
Long-Term Investments	1,612	2,055	2,810	2,085	5,255	5,200
Other Intangible Assets	4,605	5,208	5,772	5,935	5,964	5,774
Long-Term Accounts Receivable	-0	0	0	0	-0	-0
Long-Term Deferred Tax Assets	2,071	1,873	1,491	1,702	1,695	1,841
Other Long-Term Assets	779.17	1,676	1,227	1,737	2,560	1,459
Total Assets	217,568	217,627	191,658	179,129	164,434	147,894

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	31,811	32,912	28,212	24,259	18,270	14,808
Accrued Expenses	459.5	407.51	429.19	503.94	392.33	352.2
Short-Term Debt	13,000	14,300	22,000	22,600	16,100	13,000
Current Portion of Long-Term Debt	18,717	18,717	396.93	5,729	-	-
Current Portion of Leases	780.84	542.23	323.64	527.75	467.88	208.07
Current Income Taxes Payable	533.44	2,036	2,034	333.08	671.62	-
Other Current Liabilities	14,087	11,758	9,486	9,411	12,903	26,086
Total Current Liabilities	79,389	80,672	62,881	63,363	48,805	54,453
Long-Term Debt	3,488	3,687	22,404	18,750	25,000	10,000
Long-Term Leases	1,807	1,737	105.11	38.05	236.53	204.61
Other Long-Term Liabilities	180.48	164.88	1,043	230.67	238.65	435.51
Total Liabilities	84,865	86,261	86,433	82,382	74,280	65,094

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	15,992	15,992	6,966	5,629	5,629	5,629
Additional Paid-In Capital	73,505	73,505	64,808	31,809	31,809	31,809
Retained Earnings	44,293	42,875	34,217	31,972	27,805	23,566
Comprehensive Income & Other	-1,088	-1,006	-766.15	-706.36	-114.63	-536.01
Total Common Equity	132,702	131,366	105,224	68,704	65,129	60,469
Shareholders' Equity	132,702	131,366	105,224	96,747	90,154	82,800
Total Liabilities & Equity	217,568	217,627	191,658	179,129	164,434	147,894

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	37,793	38,983	45,230	47,645	41,804	23,413
Net Cash (Debt)	-29,471	-31,730	-40,676	-43,771	-37,274	-15,190
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-918.61	-1006.61	-1449.67	-3907.82	-33296.60	-13570.02
Filing Date Shares Outstanding	31.71	31.98	37.77	11.2	1.12	1.12
Total Common Shares Outstanding	31.71	31.98	37.77	11.2	1.12	1.12
Working Capital	57,914	57,888	52,776	39,557	35,049	24,950
Book Value Per Share	4184.91	4107.21	2785.92	6133.81	58180.06	54019.63
Tangible Book Value	128,097	126,157	99,452	62,769	59,165	54,695
Tangible Book Value Per Share	4039.68	3944.37	2633.09	5603.93	52852.12	48861.86
Land	9,849	9,849	9,857	9,857	11,737	11,737
Buildings	35,208	34,766	32,131	31,436	9,520	9,240
Machinery	54,862	54,060	50,824	48,467	27,318	24,767
Construction In Progress	10,668	6,041	2,968	622	40,849	30,800